Outcomes By Best Response with Hypomethylating Agent Plus Venetoclax in Adults with Previously Untreated Acute Myeloid Leukemia

MLA

Rami S. Komrokji, et al. “Outcomes By Best Response with Hypomethylating Agent Plus Venetoclax in Adults with Previously Untreated Acute Myeloid Leukemia.” Blood, vol. 138, Nov. 2021, p. 2292. EBSCOhost, https://doi.org/10.1182/blood-2021-149782.

APA

Rami S. Komrokji, Kendra Sweet, Akriti G Jain, Virginia O. Volpe, Eric Padron, David A. Sallman, Onyee Chan, & Jeffrey E. Lancet. (2021). Outcomes By Best Response with Hypomethylating Agent Plus Venetoclax in Adults with Previously Untreated Acute Myeloid Leukemia. Blood, 138, 2292. https://doi.org/10.1182/blood-2021-149782

Chicago

Rami S. Komrokji, Kendra Sweet, Akriti G Jain, Virginia O. Volpe, Eric Padron, David A. Sallman, Onyee Chan, and Jeffrey E. Lancet. 2021. “Outcomes By Best Response with Hypomethylating Agent Plus Venetoclax in Adults with Previously Untreated Acute Myeloid Leukemia.” Blood 138 (November): 2292. doi:10.1182/blood-2021-149782.